Expert advocates more clinical trials in Africa
A multinational biotechnology healthcare company, Roche, has lamented the low inclusion of Africa in global pharma studies, revealing that only 2.4 per cent of patients from the continent are enrolled in annual global clinical trials. According to the company, African patients make up only about two per cent of genomic data for clinical trials despite